Verdence Capital Advisors LLC Selecta Biosciences Inc Transaction History

Verdence Capital Advisors LLC

  • $1.23 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021
SELL
$2.82 - $5.01 $47,940 - $85,170
-17,000 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$1.64 - $3.42 $1,640 - $3,420
1,000 Added 6.25%
17,000 $52,000
Q3 2020

Nov 09, 2020
BUY
$2.18 - $2.84 $34,880 - $45,440
16,000 New
16,000 $40,000

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email